Literature DB >> 16316935

Factors affecting trust in on-line prescription drug information and impact of trust on behavior following exposure to DTC advertising.

Jisu Huh1, Denise E DeLorme, Leonard N Reid.   

Abstract

Despite growing concerns about the quality and accuracy of Internet-based prescription drug information, there has been very little empirical research on consumers' perceptions of the trustworthiness of on-line drug information. In this article, we report on a study modeled after that of Menon, Deshpande, Perri, and Zinkhan (2002) in Health Marketing Quarterly that reexamines how key demographic, predispositional, and media factors are associated with consumer trust in on-line prescription drug information and the impact of trust in on-line drug information on ad-promoted behavior following exposure to direct-to-consumer (DTC) advertising. Four major findings are reported: (1) on-line drug information is not highly trusted; (2) trust in on-line drug information is not differentially affected by consumer demographic or predispositional characteristics; (3) trust in the traditional media of DTC advertising is predictive of trust in on-line drug information; and (4) trust in on-line drug information is associated directly with specific types of ad-promoted behavior following exposure to DTC advertising. Implications and recommendations are offered based on the results.

Mesh:

Year:  2005        PMID: 16316935     DOI: 10.1080/10810730500326716

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  9 in total

1.  Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.

Authors:  Jessica T DeFrank; Nancy D Berkman; Leila Kahwati; Katherine Cullen; Kathryn J Aikin; Helen W Sullivan
Journal:  Health Commun       Date:  2019-04-11

2.  Physician Interpretation of Data of Uncertain Clinical Utility in Oncology Prescription Drug Promotion.

Authors:  Vanessa Boudewyns; Amie C O'Donoghue; Ryan S Paquin; Kathryn J Aikin; Kate Ferriola-Bruckenstein; Victoria M Scott
Journal:  Oncologist       Date:  2021-09-28

3.  Public trust in genomic risk assessment for type 2 diabetes mellitus.

Authors:  Rachel Mills; William Barry; Susanne B Haga
Journal:  J Genet Couns       Date:  2013-12-03       Impact factor: 2.537

4.  General public knowledge, perceptions and practice towards pharmaceutical drug advertisements in the Western region of KSA.

Authors:  Mahmoud S Al-Haddad; Fayez Hamam; Sami M Al-Shakhshir
Journal:  Saudi Pharm J       Date:  2013-04-06       Impact factor: 4.330

5.  Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey.

Authors:  Kathryn J Aikin; Helen W Sullivan; Jennifer Berktold; Karen L Stein; Victoria J Hoverman
Journal:  Health Mark Q       Date:  2021-07-09

6.  Online Health Information Seeking for Self and Child: An Experimental Study of Parental Symptom Search.

Authors:  Christian Kubb; Heather M Foran
Journal:  JMIR Pediatr Parent       Date:  2022-05-09

7.  Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment.

Authors:  Ilene L Hollin; Jennifer Gerard Ball
Journal:  Explor Res Clin Soc Pharm       Date:  2022-09-19

8.  Compliance of disease awareness campaigns in printed Dutch media with national and international regulatory guidelines.

Authors:  Teresa Leonardo Alves; Auramarina F Martins de Freitas; Martine E C van Eijk; Aukje K Mantel-Teeuwisse
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

9.  'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.

Authors:  Neda Khalil Zadeh; Kirsten Robertson; James A Green
Journal:  BMJ Open       Date:  2017-12-06       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.